Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $189000.0.

  • Traws Pharma's Change in Accured Expenses rose 12200.23% to $189000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $132000.0, marking a year-over-year increase of 10235.08%. This contributed to the annual value of -$5.2 million for FY2024, which is 79213.68% down from last year.
  • Traws Pharma's Change in Accured Expenses amounted to $189000.0 in Q3 2025, which was up 12200.23% from $74000.0 recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Change in Accured Expenses registered a high of $631000.0 during Q2 2022, and its lowest value of -$4.1 million during Q2 2024.
  • Its 5-year average for Change in Accured Expenses is -$376052.6, with a median of -$69000.0 in 2023.
  • In the last 5 years, Traws Pharma's Change in Accured Expenses surged by 58914.73% in 2022 and then plummeted by 114492.75% in 2024.
  • Over the past 5 years, Traws Pharma's Change in Accured Expenses (Quarter) stood at $383000.0 in 2021, then skyrocketed by 59.27% to $610000.0 in 2022, then crashed by 87.7% to $75000.0 in 2023, then soared by 528.0% to $471000.0 in 2024, then plummeted by 59.87% to $189000.0 in 2025.
  • Its last three reported values are $189000.0 in Q3 2025, $74000.0 for Q2 2025, and -$602000.0 during Q1 2025.